Lv3
356 积分 2024-05-25 加入
Rewiring STAT signaling from the cell surface with Trikine immunotherapeutics
4天前
已完结
Interleukin-18 armours antitumour immune effectors
4天前
已完结
The global patent landscape of bispecific antibodies: technological innovations and therapeutic applications
8天前
已完结
Multi-TACs: Targeting Solid Tumors with Multiple Immune Cell Co-engagers
22天前
已完结
Progress in the development of cytokine armoured CAR T cells
25天前
已完结
A guide to CAR T cell therapies: development, current status and future prospects
25天前
已完结
New insights into progenitor exhausted T cell populations
25天前
已完结
T cell engagers in autoimmune diseases
25天前
已完结
Efficient generation of epitope-targeted antibodies with Germinal
1个月前
已完结
Characterization of JNJ-80948543, a Novel CD79bxCD20xCD3 Trispecific T-Cell Redirecting Antibody for the Treatment of B-Cell Non-Hodgkin Lymphoma
1个月前
已完结
皖公网安备34019202002308
